Experience of using rituximab for recurrent non-Hodgkin lymphoma in elderly patients of the Orel region

<p>This article summarizes the results of 10 patients (6 men and 4 women) with recurrent non-Hodgkin lymphoma treating with using of rituximab. The diagnosis was confirmed by histological examination with immunohistochemistry. The average patient age was 61.1 years. All patients received from...

Full description

Bibliographic Details
Main Authors: R. A. Golubenko, G. B. Gromov, V. I. Vishnevskiy
Format: Article
Language:Russian
Published: ABV-press 2014-07-01
Series:Онкогематология
Subjects:
Online Access:http://oncohematology.abvpress.ru/index.php/ongm/article/view/96
_version_ 1828046806842343424
author R. A. Golubenko
G. B. Gromov
V. I. Vishnevskiy
author_facet R. A. Golubenko
G. B. Gromov
V. I. Vishnevskiy
author_sort R. A. Golubenko
collection DOAJ
description <p>This article summarizes the results of 10 patients (6 men and 4 women) with recurrent non-Hodgkin lymphoma treating with using of rituximab. The diagnosis was confirmed by histological examination with immunohistochemistry. The average patient age was 61.1 years. All patients received from 6 to 8 chemotherapy courses and 8 rituximab injections, no one patient was withdrawn from therapy. Rituximab treatment in combination with chemotherapy was successful in 7 (70 %) of 10 patients. The major therapy response was a high frequency of CR — 40 %, slightly exceeding the rate of PR — 30 %. Rituximab has been used successfully in the treatment of elderly patients without additional toxicity, which makes it possible to use the drug on an outpatient basis.</p>
first_indexed 2024-04-10T18:31:33Z
format Article
id doaj.art-f3f5ef209b5f4748be5d16ce26cb034d
institution Directory Open Access Journal
issn 1818-8346
language Russian
last_indexed 2024-04-10T18:31:33Z
publishDate 2014-07-01
publisher ABV-press
record_format Article
series Онкогематология
spelling doaj.art-f3f5ef209b5f4748be5d16ce26cb034d2023-02-02T04:12:55ZrusABV-pressОнкогематология1818-83462014-07-0162811111Experience of using rituximab for recurrent non-Hodgkin lymphoma in elderly patients of the Orel regionR. A. Golubenko0G. B. Gromov1V. I. Vishnevskiy2Medical Institute of Orel State University Orel regional hospitalMedical Institute of Orel State UniversityMedical Institute of Orel State University<p>This article summarizes the results of 10 patients (6 men and 4 women) with recurrent non-Hodgkin lymphoma treating with using of rituximab. The diagnosis was confirmed by histological examination with immunohistochemistry. The average patient age was 61.1 years. All patients received from 6 to 8 chemotherapy courses and 8 rituximab injections, no one patient was withdrawn from therapy. Rituximab treatment in combination with chemotherapy was successful in 7 (70 %) of 10 patients. The major therapy response was a high frequency of CR — 40 %, slightly exceeding the rate of PR — 30 %. Rituximab has been used successfully in the treatment of elderly patients without additional toxicity, which makes it possible to use the drug on an outpatient basis.</p>http://oncohematology.abvpress.ru/index.php/ongm/article/view/96non-Hodgkin’s lymphomarelapserituximabelderlychemotherapy
spellingShingle R. A. Golubenko
G. B. Gromov
V. I. Vishnevskiy
Experience of using rituximab for recurrent non-Hodgkin lymphoma in elderly patients of the Orel region
Онкогематология
non-Hodgkin’s lymphoma
relapse
rituximab
elderly
chemotherapy
title Experience of using rituximab for recurrent non-Hodgkin lymphoma in elderly patients of the Orel region
title_full Experience of using rituximab for recurrent non-Hodgkin lymphoma in elderly patients of the Orel region
title_fullStr Experience of using rituximab for recurrent non-Hodgkin lymphoma in elderly patients of the Orel region
title_full_unstemmed Experience of using rituximab for recurrent non-Hodgkin lymphoma in elderly patients of the Orel region
title_short Experience of using rituximab for recurrent non-Hodgkin lymphoma in elderly patients of the Orel region
title_sort experience of using rituximab for recurrent non hodgkin lymphoma in elderly patients of the orel region
topic non-Hodgkin’s lymphoma
relapse
rituximab
elderly
chemotherapy
url http://oncohematology.abvpress.ru/index.php/ongm/article/view/96
work_keys_str_mv AT ragolubenko experienceofusingrituximabforrecurrentnonhodgkinlymphomainelderlypatientsoftheorelregion
AT gbgromov experienceofusingrituximabforrecurrentnonhodgkinlymphomainelderlypatientsoftheorelregion
AT vivishnevskiy experienceofusingrituximabforrecurrentnonhodgkinlymphomainelderlypatientsoftheorelregion